¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"low birth weight infant"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • birth rate
    Ãâ»ý·ü
  • birth trauma
    ºÐ¸¸¿Ü»ó
  • birth-death ratio
    Ãâ»ý»ç¸Áºñ
  • bony birth canal
    »ÀÃâ»ê±æ, ÀÛÀº°ñ¹Ý
  • cross birth
    ȾÀ§ºÐ¸¸
  • crude birth rate
    º¸ÅëÃâ»ý·ü, Á¶Ãâ»ý·ü
  • full term birth
    ¸¸±âÃâ»ý
  • live birth
    »ýÁ¸Ãâ»ý
  • live birth rate
    »ý¾ÆÃâ»ý·ü
  • low back pain
    Ç㸮ÅëÁõ, ¿äÅë
  • low cervical cesarean section
    ¾Æ·¡ÀڱøñÁ¦¿ÕÀý°³(¼ú), ÇϺÎÀڱðæºÎÁ¦¿ÕÀý°³(¼ú)
  • low density lipoprotein
    Àú¹ÐµµÁöÁú´Ü¹éÁú
  • low dose rate
    Àú¼±·®·ü
  • low dose rate irradiation
    Àú¼±·®·üÁ¶»ç
  • low echo area
    ³·Àº¸Þ¾Æ¸®¿µ¿ª, Àú¿¡ÄÚ¿µ¿ª
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • low fever
    ¹Ì¿­
  • low-output heart failure
    Àú¹ÚÃâ½ÉÀåºÎÀü
  • low-pass filter
    ÀúÅë°ú°Å¸£°³, ÀúÅë°ú¿©°ú±â
  • low grade glioma
    ¾ç¼º½Å°æ¾Æ±³Á¾
  • low-tension glaucoma
    Àú¾È¾Ð³ì³»Àå
  • low pressure hydrocephalus
    Àú¾Ð¹°³úÁõ, Àú¾Ð¼öµÎÁõ
  • low renin hypertension
    Àú·¹´Ñ°íÇ÷¾Ð
  • low dose rate irradiation
    Àú¼±·®À²Á¶»ç
  • low signal intensity
    Àú½ÅÈ£°­µµ
  • low signal
    Àú½ÅÈ£, ³·Àº½ÅÈ£
  • low back pain
    ¿äÅë
  • low cervical cesarean section
    ¾Æ·¡ÀڱøñÁ¦¿ÕÀý°³¼ú, ÇϺÎÀڱðæºÎÁ¦¿ÕÀý°³¼ú
  • low dose rate
    Àú¼±·®·ü
  • low field magnetic resonance scanner
    ÀúÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • low temperature resin
    Àú¿Â¼öÁö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • atomic weight
    ¿øÀÚ·®
  • average molecular weight
    Æò±ÕºÐÀÚ·®.
  • body weight
    üÁß(ô÷ñì).
  • body weight table
    ¸ö¹«°ÔÇ¥
  • body-weight ratio
    üÁß½ÅÀåºñ(ô÷ñìãóíþÝï).
  • brain weight
    ³úÁß·®(¡­ñìåÖ).
  • combining weight
    È­ÇÕ·®(ûùùêåÖ).
  • dry weight
    °ÇÁ¶Áß·®(ËëðÏñìåÖ).
  • equivalent weight
    µî°¡·®
  • equivalent weight
    µîÁß·®(ÔõñìåÖ), ´ç·®, µî°¡¹«°Ô.
  • gram atomic weight
    ±×·¥¿øÀÚ·®.
  • height weight chart
  • height-weight table
    ½ÅÀåüÁßÇ¥
  • high molecular weight kinin
    °íºÐÀÚ·®Å°´Ñ
  • high molecular weight kininogen
    °íºÐÀÚÁß·®Å°´Ï³ë°Õ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
TBLI term birth, living infant
BWt birth weight
HBW high birth weight
NBW normal birth weight
ULBW ultralow birth weight
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
SGA small for gestational age infant
LMWH Low Molecular Weight Heparin
LMWP Low Molecular Weight Proteins
LMW heparin Low Molecular Weight heparin
LMW Low molecular weight
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • low frequency
    ÀúÁÖÆÄ
    Á֯ļö°¡ ³·Àº ÆÄ. Áï, ÀüÀÚ±âÆÄÀÇ Á֯ļö¿¡ ÀÇÇÑ ºÐ·ù·Î¼­, º¸Åë 10 kHz ÀÌÇϸ¦ ¸»ÇÑ´Ù. ¿Àµð¿À
  • low frequency therapeutic apparatus
    ÀúÁÖÆÄ Ä¡·á±â
  • low fusing porcelain
    Àú¿Â ¿ëÀ¶ µµÀç
    Ä¡°ú¿ë µµÀçÀÇ Á¾·ùÀε¥ 1600¡Æ¡­2000¢µ¿¡¼­ 󸮵Ǵ µµÀçÀÌ´Ù.
  • low lip line
    Çϼø ¼±
    ÀÔÀ» °íÀÇ·Î Å©°Ô ¹ú¸®°Å³ª ¶Ç´Â ¿ôÀ» ¶§¿¡ À§Ä¡ÇÏ´Â ÃÖÇÏÀ§ÀÇ À§Ä¡¸¦ ¶æÇÒ ¶§µµ ÀÖ°í, »ó¼øÀÌ Á¤Áö »óÅ¿¡ ÀÖÀ» ¶§ ±× ÇÏ¿¬´ÜÀ» °¡¸®Å°±âµµ ÇÑ´Ù.
  • low output syndrome
    Àú ¹ÚÃâ·® ÁõÈıº
  • low pressure hydrocephalus
    Àú¾Ð¼º ¼öµÎÁõ
  • low salt syndrome
    Àú¿° ÁõÈıº
  • low silver amalgam
    ÀúÀº ¾Æ¸»°¨
  • low temperature
    Àú¿Â
  • low voltage
    Àú Àü¾Ð
  • low-density lipoprotein
    Àú¹Ðµµ Áö¹æ ´Ü¹é
  • low-frequency wave
    ÀúÁÖÆÄ
  • low-pitched
    ³»¸®±î´Â
  • low-threshold mechanoreceptor
    Àú¿ªÄ¡ ±â°è ¼ö¿ë±â
  • myofascial low back pain
    ±Ù¸·¼º ¿äÅë
    ¿äÅëÀ» ÁַΠȣ¼ÒÇÏ´Â ÁúȯÀÇ ÇϳªÀ̰í ô¼ö ½Å°æÀÌ ¿äºÎ ±Ù¸·À» ¶Õ°í ³ª¿À´Â ºÎÀ§¿¡ ¾ÐÅë ¹× ¿îµ¿ÅëÀÌ ³ªÅ¸³­´Ù. ¿øÀÎÀ¸·Î¼­´Â ±¹¼Ò¿¡¼­ÀÇ ·çĿƼÁò¼³µµ Àִµ¥ ôÃß ºÐ¸®Áõ µî ¿ÜÀÇ ÁúȯÀÎ °æ¿ì¿¡´Â Áõ»óÀ¸·Î ³ªÅ¸³ª´Â ¼öµµ ÀÖ°í °ü·ÃµÇ´Â ÅëÁõ ¿äÀÎÀ̳ª ô¼ö ½Å°æ ÈÄÁöÀÇ Àڱؼº Ç×Áø µîÀ» »ý°¢ÇÒ ¼ö ÀÖ´Ù. Ä¡·á·Î¼­´Â ±¹¼Ò ¸¶ÃëÁ¦³ª ½ºÅ×·ÎÀ̵åÁ¦ÀÇ ±¹¼Ò Áֻ簡 ÀÌ·ç¾îÁö°Å³ª ±Ù¸· Àý°³ ³»Áö ÀýÁ¦¼úÀÌ ÀÌ·ç¾îÁö´Â ¼öµµ ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
kininogen, high-molecular-weight A plasma protein, molecular weight of 110 kD, that normally exists in plasma in a 1:1 complex with prekallikrein. Hmwk is split by plasma kallikrein to produce bradykinin. The complex is a cofactor in the activation of coagulation factor xii. The product of this reaction, xiia, in turn activates prekallikrein to kallikrein.
(12 Dec 1998)
unit of weight See: unit of mass.
(05 Mar 2000)
Bayley Scales of Infant Development A psychological test used to measure the developmental progress of infants over the first two and one-half years of life; consists of three scales: mental, motor, and behaviour record.
(05 Mar 2000)
rate, infant mortality The number of children dying under a year of age divided by the number of live births that year. The infant mortality rate in the united states, which was 12.5 per 1,000 live births in 1980, fell to 9.2 per 1,000 live births in 1990.
(12 Dec 1998)
Cattell Infant Intelligence Scale A standardised scale for assessment of the cognitive development of infants between the ages of 3 and 30 months.
(05 Mar 2000)
mortality rate, infant The number of children dying under a year of age divided by the number of live births that year. The infant mortality rate in the united states, which was 12.5 per 1,000 live births in 1980, fell to 9.2 per 1,000 live births in 1990.
(12 Dec 1998)
postmature infant A baby born 1 week (7 days) or more after the usual 9 months (280 days) of gestation.
(12 Dec 1998)
post-term infant A baby born 2 weeks (14 days) or more after the usual 9 months (280 days) of gestation, as calculated from the last menstrual period (lmp). This is an important calculation, since, if delivery is delayed 3 weeks beyond term, the infant mortality rate skyrockets to 3 times normal.
(12 Dec 1998)
preterm infant An infant with gestational age of less than 37 completed weeks (259 completed days).
(05 Mar 2000)
stillborn infant An infant who shows no evidence of life after birth.
Compare: liveborn infant.
(05 Mar 2000)
sudden infant death The abrupt and unexplained death of an apparently healthy infant under one year of age, remaining unexplained after a thorough case investigation, including performance of a complete autopsy, examination of the death scene, and review of the clinical history. (expert panel of the national institute of child health and human development in paediatric pathology, v.11, no.5, sept-oct 1991, p681)
(12 Dec 1998)
sudden infant death syndrome <syndrome> May affect infants of any age, but some risk factors have been identified: term infants who have had a life-threatening period of apnoea (not breathing), premature infants of low birth weight, siblings of infants who have succumbed to sudden infant death syndrome and infants of substance abusing mothers.
Peak age is at 2.5 months and 4 months, but can range from 1 month to 1 year. High risk infants should have home monitoring done. It is recommended that the less than 4 month old infant should sleep on their back.
Synonym: cot death syndrome.
Incidence: 2 per 1,000 live births.
Acronym: SIDS
(27 Sep 1997)
incubators, infant Apparatus for maintaining a premature infant in an environment of proper temperature and humidity.
(12 Dec 1998)
infant The child up to 24 months of age. The word infant is from the latin meaning not speaking.
(12 Dec 1998)
infant behaviour Any observable response or action of a neonate or infant up through the age of 23 months.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • low
    ¼ÒÀÇ ¿ïÀ½¼Ò¸®
  • low
    (¼Ò µûÀ§°¡) ¿ò¸ÅÇÏ°í ¿ï´Ù;±½Àº ¸ñ¼Ò¸®·Î ¸»ÇÏ´Ù
  • low comedy
    Àú¼ÓÇÑ Äڹ̵ð !
  • low frequency
    ÀúÁÖÆÄ
  • low relief
    ¾èÀº µ¸À»»õ±è
  • low tea
    °£´ÜÇÑ ½Ä»ç
  • low tide
    °£Á¶;½ä¹°
  • low water
    °£Á¶;ÃÖÀú¼ö¸é
  • new low
    X;»õ·Î¿î ÃÖÀú °¡°Ý;ÃÖÀú±â·Ï(cf.NEW HIGH)
  • very low frequency
    ÃÊÀåÆÄ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á